Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.31 |
| ▸ | STAT6 | P42226 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28912994 | 0.86 | CHRM5 (0.42) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL30917891 | 0.78 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL18154851 | 0.78 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL16607366 | 0.77 | MEN1 (0.49) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL30839344 | 0.77 | MEN1 (0.49) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A | |
| SCHEMBL3966571 | 0.74 | MGAM (0.50) | ALDH1A1POLBTSHRGAA | |
| SCHEMBL8912811 | 0.74 | MGAM (0.50) | ALDH1A1POLBTSHRGAA | |
| SCHEMBL11852921 | 0.74 | — | — | |
| SCHEMBL2373233 | 0.74 | MGAM (0.50) | ALDH1A1POLBTSHRGAA | |
| SCHEMBL9250667 | 0.74 | ALDH1A1 (0.53) | ALDH1A1SMN1; SMN2MEN1POLBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2051614-B1 | DUSTER SYSTEM FOR DAMP AND DRY DUSTING | PROCTER & GAMBLE (US) | 2014-11-05 | — | — | EP | disclosed |
| US-8808678-B2 | Use and application of defined zwitterionic copolymer | THE PROCTER & GAMBLE COMPANY (US) | 2014-08-19 | — | — | US | disclosed |
| US-20140047653-A1 | USE AND APPLICATION OF DEFINED ZWITTERIONIC COPOLYMER | THE PROCTER & GAMBLE COMPANY (US) | 2014-02-20 | — | — | US | disclosed |
| EP-2287214-B1 | Use and application of defined zwitterionic copolymer | PROCTER & GAMBLE (US) | 2012-07-25 | — | — | EP | disclosed |
| EP-2287214-A1 | Use and application of defined zwitterionic copolymer | The Procter & Gamble Company (US) | 2011-02-23 | — | — | EP | disclosed |
| US-7842654-B2 | Method, articles and compositions for cleaning bathroom surfaces | THE PROCTER & GAMBLE COMPANY (US) | 2010-11-30 | — | — | US | disclosed |
| EP-1434847-B1 | PRE-MOISTENED WIPE FOR TREATING A SURFACE | PROCTER & GAMBLE (US) | 2009-09-02 | — | — | EP | disclosed |
| EP-1678285-B1 | FLOOR CLEANING AND GLOSS ENHANCING COMPOSITIONS | PROCTER & GAMBLE (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-2051614-A1 | DUSTER SYSTEM FOR DAMP AND DRY DUSTING | The Procter and Gamble Company (US) | 2009-04-29 | — | — | EP | disclosed |
| US-7417000-B2 | Pre-moistened wipe comprising polymeric biguanide for treating a surface | THE PROCTER & GAMLE COMPANY (US) | 2008-08-26 | — | — | US | disclosed |
| US-6814088-B2 | AT LEAST ONE LOW RESIDUE SURFACTANT SUCH AS ALKYL POLYGLYCOSIDE AND/OR AN ALKYL ETHOXYLATE SURFACTANT, AND A POLYBIGUANIDE, AT AN ACIDIC PH; CLEANING HARD SURFACES | THE PROCTER & GAMBLE COMPANY | 2004-11-09 | — | — | US | disclosed |
| EP-1434847-A1 | PRE-MOISTENED WIPE FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2004-07-07 | — | — | EP | disclosed |
| EP-1434837-A1 | AQUEOUS COMPOSITIONS FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2004-07-07 | — | — | EP | disclosed |
| EP-1434846-A1 | PRE-MOISTENED WIPE COMPRISING POLYMERIC BIGUANIDE FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2004-07-07 | — | — | EP | disclosed |
| US-20030143909-A1 | Pre-moistened wipe comprising polymeric biguanide for treating a surface | THE PROCTER & GAMBLE COMPANY | 2003-07-31 | — | — | US | disclosed |
| US-20030119705-A1 | Pre-moistened wipe for treating a surface | THE PROCTER & GAMBLE COMPANY | 2003-06-26 | — | — | US | disclosed |
| US-20030099570-A1 | Aqueous compositions for treating a surface | THE PROCTER & GAMBLE COMPANY | 2003-05-29 | — | — | US | disclosed |
| WO-2003031558-A1 | PRE-MOISTENED WIPE FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003031546-A1 | AQUEOUS COMPOSITIONS FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-17 | — | — | WO | disclosed |
| WO-2003031557-A1 | PRE-MOISTENED WIPE COMPRISING POLYMERIC BIGUANIDE FOR TREATING A SURFACE | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030099570-A1 | Aqueous compositions for treating a surface | MSR1, ALG1, SIGLEC7 | ALDH1A1 3533/4885SMN1; SMN2 3573/4885MEN1 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.